GlassScriptPhysician profile
Nicholas R White
NPI 1073801106
$15,982.82
in general payments reported to CMS, 2019-2025
17 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,597 · 2020: $45.17 · 2021: $980 · 2022: $4,448 · 2023: $2,264 · 2024: $2,439 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,549 · Food and Beverage: $1,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,548.50 |
| Food and Beverage | $1,364.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,432.65 | 2019 | |
| Peerless Surgical INC. | $4,027.94 | 2021-2025 | |
| Arthrex, INC. | $3,831.58 | 2021-2024 | |
| Axogen | $1,758.68 | 2022 | |
| Depuy Synthes Sales INC. | $264.33 | 2023-2025 | Va-Lcp, Motoband, Na |
| Endo Pharmaceuticals INC. | $153.36 | 2021-2024 | Xiaflex |
| Smith+Nephew, INC. | $88.38 | 2020-2024 | Stravix |
| Tela Bio, INC. | $83.20 | 2019-2020 | |
| Skeletal Dynamics INC | $77.44 | 2023 | Ijs, Geminus, Implate |
| Integra Lifesciences Corporation | $66.60 | 2019-2022 | |
| Endo USA, INC. | $53.55 | 2024-2025 | Xiaflex |
| Kerecis Limited | $43.88 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Osiris Therapeutics INC. | $29.19 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $26.10 | 2019 | |
| Acell, INC. | $19.02 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $15.23 | 2020 | |
| Bioventus LLC | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.